Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.

Abstract:

:Rituximab is a monoclonal antibody directed against the CD20 antigen expressed on B cells and widely used in the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis. There is a growing amount of literature which suggests that rituximab may be useful for inflammatory ocular diseases and intraocular lymphoma. Few cases have been reported on treatment of refractory scleritis, peripherative ulcerative keratitis, uveitis and ocular surface inflammatory disorders. Rituximab may be effective in the treatment of ocular inflammatory diseases in particular the most aggressive, recalcitrant and sight-threatening forms of inflammation such as uveitis associated to juvenile idiopathic arthritis. We review the literature covering the use of Rituximab in these conditions and report our results on the efficacy of Rituximab in the treatment of 8 children with very severe and long-standing uveitis who failed to respond to one or more TNF blockers. Our patients showed improvement in activity of uveitis, reduction of concomitant corticosteroids and immunosuppressants after a mean follow-up time of 14.87 months on rituximab. No serious adverse events were encountered in our treated patients. Although further studies are needed for assessing the efficacy of rituximab and the exact dosing regimen, rituximab may be considered as a treatment alternative in patients with the most aggressive forms of inflammatory ocular diseases who fail to respond to conventional and anti-TNF immunosuppressive agents.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Miserocchi E,Pontikaki I,Modorati G,Gattinara M,Meroni PL,Gerloni V

doi

10.1016/j.autrev.2011.07.001

subject

Has Abstract

pub_date

2011-11-01 00:00:00

pages

35-9

issue

1

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(11)00153-4

journal_volume

11

pub_type

杂志文章,评审
  • Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases.

    abstract::Systemic rheumatic diseases (SRDs) are associated with accelerated atherosclerosis. It has recently been recognised that chronic inflammation is an important factor in the development of atherosclerotic plaque and endothelial dysfunction. The levels of biomarkers such as serum pentraxin 3 (PTX3), an innate immunity pr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.001

    authors: Atzeni F,Turiel M,Hollan I,Meroni P,Sitia S,Tomasoni L,Sarzi-Puttini P

    更新日期:2010-10-01 00:00:00

  • Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management.

    abstract::Kawasaki disease (KD) is a vasculitis that affects mainly children of 6 months to 4 years old. It is important to be early recognised so as to limit the inflammatory cascade that may lead to aneurysmatic dilatations of coronary arteries. The causative agent of KD has not been still indentified and the aetiopathogeneti...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.005

    authors: Alexoudi I,Kanakis M,Kapsimali V,Vaiopoulos G

    更新日期:2011-07-01 00:00:00

  • CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis.

    abstract:BACKGROUND:Myositis is a heterogeneous group of muscular auto-immune diseases with clinical and pathological criteria that allow the classification of patients into different sub-groups. Inclusion body myositis is the most frequent myositis above fifty years of age. Diagnosing inclusion body myositis requires expertise...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2019.02.003

    authors: Dzangué-Tchoupou G,Mariampillai K,Bolko L,Amelin D,Mauhin W,Corneau A,Blanc C,Allenbach Y,Benveniste O

    更新日期:2019-04-01 00:00:00

  • Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.

    abstract::Mesenchymal stem cells (MSCs) are non-hematopoietic, multipotent progenitor cells which can be isolated from various human adult tissues. In recent years, MSCs have been shown to possess broad immunoregulatory capabilities, modulating both adaptive and innate immunity. This review discusses the documented immunomodula...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.01.005

    authors: Ben-Ami E,Berrih-Aknin S,Miller A

    更新日期:2011-05-01 00:00:00

  • Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature.

    abstract:BACKGROUND:Steroid-responsive encephalopathy and associated autoimmune thyroiditis (SREAT) is characterized by encephalopathy and the presence of antithyroid antibodies. We describe the clinical presentation, outcome and treatments for SREAT by a systematic review of the literature. METHODS:MEDLINE via PubMed, Web of ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.09.008

    authors: Laurent C,Capron J,Quillerou B,Thomas G,Alamowitch S,Fain O,Mekinian A

    更新日期:2016-12-01 00:00:00

  • Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.

    abstract:BACKGROUND:The gold standard for secondary thromboprophylaxis in APS is long term anticoagulation with vitamin K antagonists (VKAs). Because of their widespread use and potential advantages of directs oral anticoagulants (DOACs) over VKAs, they have been prescribed in APS without definitive evidence of their safety and...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2020.102711

    authors: Dufrost V,Wahl D,Zuily S

    更新日期:2021-01-01 00:00:00

  • Hashimoto thyroiditis: clinical and diagnostic criteria.

    abstract::Hashimoto thyroiditis (HT), now considered the most common autoimmune disease, was described over a century ago as a pronounced lymphoid goiter affecting predominantly women. In addition to this classic form, several other clinico-pathologic entities are now included under the term HT: fibrous variant, IgG4-related va...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.01.007

    authors: Caturegli P,De Remigis A,Rose NR

    更新日期:2014-04-01 00:00:00

  • Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.

    abstract:OBJECTIVE:We investigated the effectiveness of rituximab (an anti-CD20 monoclonal antibody) in patients with eosinophilic granulomatosis with polyangiitis (EGPA). METHODS:We performed a systematic literature review from the inception dates until July 20, 2020 for articles reporting rituximab administration to treat EG...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102737

    authors: Akiyama M,Kaneko Y,Takeuchi T

    更新日期:2021-02-01 00:00:00

  • Incidence and nature of infectious disease in patients treated with anti-TNF agents.

    abstract::Tumor necrosis factor alpha (TNF-alpha) inhibitors offer a targeted therapeutic strategy that contrasts with the nonspecific immunosuppressive agents traditionally used to treat most inflammatory diseases. These biologic agents have had a significant impact in ameliorating the signs and symptoms of inflammatory rheuma...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.08.006

    authors: Raychaudhuri SP,Nguyen CT,Raychaudhuri SK,Gershwin ME

    更新日期:2009-12-01 00:00:00

  • Regulation of neurovascular coupling in autoimmunity to water and ion channels.

    abstract::Much progress has been made in understanding autoimmune channelopathies, but the underlying pathogenic mechanisms are not always clear due to broad expression of some channel proteins. Recent studies show that autoimmune conditions that interfere with neurovascular coupling in the central nervous system (CNS) can lead...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.11.010

    authors: Jukkola P,Gu C

    更新日期:2015-03-01 00:00:00

  • Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease.

    abstract::Numerous inflammatory rheumatic diseases occurring in premenopausal women require the use of high doses of glucocorticoids (GC). It was believed for many years that premenopausal women were, at least to some extent, protected from bone loss associated with GC therapy. However, epidemiological studies performed in prem...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(03)00056-9

    authors: Franchimont N,Canalis E

    更新日期:2003-06-01 00:00:00

  • Bone mineral density and vitamin D status in systemic lupus erythematosus (SLE): A systematic review.

    abstract::Despite the improvement in the quality of life of patients with SLE due to scientific and technological advances, SLE remains a disease that over the years may produce irreversible damage to patients. Osteoporosis and secondary bone fractures are two of the major causes of irreparable injury in patients with SLE. Vita...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.09.011

    authors: Salman-Monte TC,Torrente-Segarra V,Vega-Vidal AL,Corzo P,Castro-Dominguez F,Ojeda F,Carbonell-Abelló J

    更新日期:2017-11-01 00:00:00

  • Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.

    abstract::Intravenous immunoglobulin (IVIg) is used for replacement therapy in immunodeficiency states and for immunomodulation of various autoimmune diseases. Several case reports and series support a beneficial role of IVIg in systemic lupus erythematosus (SLE), both as salvage immunotherapy and in control of disease activity...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.09.002

    authors: Sherer Y,Shoenfeld Y

    更新日期:2006-02-01 00:00:00

  • Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry.

    abstract::New biologic agents have changed the paradigm of rheumatoid arthritis treatment, leading to improvement in managing patients' refractory to classical DMARDs. Anti-TNF-alpha is used as first-line treatment in patients failing to respond to classical DMARDs. However, up to 50% of patients fail to respond to these drugs ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2009.12.010

    authors: Caporali R,Sarzi-Puttini P,Atzeni F,Gorla R,Filippini M,Marchesoni A,Favalli EG,Bobbio-Pallavicini F,Montecucco C

    更新日期:2010-04-01 00:00:00

  • Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk?

    abstract::In patients with systemic auto-immune inflammatory rheumatic diseases (AIIRD) like rheumatoid arthritis the prevalence of cardiovascular disease (CVD) is increased. In the pathogenesis of AIIRD and atherosclerosis many similarities can be found in the process underlying CVD. Accumulation of inflammatory cells, in part...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.002

    authors: Jager NA,Teteloshvili N,Zeebregts CJ,Westra J,Bijl M

    更新日期:2012-07-01 00:00:00

  • Impaired clearance of dying cells in systemic lupus erythematosus.

    abstract::Impaired clearance of apoptotic cell material has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). Besides many other molecules, C1q and DNaseI contribute to an efficient clearance of dying cells. A frequently observed factor in SLE patients is the accumulation of unusually large amounts of a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.10.007

    authors: Gaipl US,Voll RE,Sheriff A,Franz S,Kalden JR,Herrmann M

    更新日期:2005-04-01 00:00:00

  • Cortactin autoantibodies in myasthenia gravis.

    abstract::Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness, fatigability, and autoantibodies against protein antigens of the muscle endplate. Antibodies against acetylcholine receptor (AChR), and less frequently against muscle-Specific Kinase (MuSK) or lipoprotein related protein 4 (LRP4) occur i...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2014.08.039

    authors: Gallardo E,Martínez-Hernández E,Titulaer MJ,Huijbers MG,Martínez MA,Ramos A,Querol L,Díaz-Manera J,Rojas-García R,Hayworth CR,Verschuuren JJ,Balice-Gordon R,Dalmau J,Illa I

    更新日期:2014-10-01 00:00:00

  • CD20: a target antigen for immunotherapy of autoimmune diseases.

    abstract::This article reviews the role of CD20 antigen in B cell function and the effectiveness and limits of passive immunotherapy with anti-CD20 monoclonal antibody (Rituximab) in the treatment of autoimmune (or immune-mediated) diseases. Active immunotherapy is a more feasible way to control these chronic diseases. A peptid...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.04.004

    authors: Perosa F,Favoino E,Caragnano MA,Prete M,Dammacco F

    更新日期:2005-11-01 00:00:00

  • Treatment of rheumatic diseases in patients with HCV and HIV infection.

    abstract::A wide variety of rheumatic diseases has been documented in the presence of hepatitis C virus (HCV) infection and in human immunodeficiency virus (HIV) infection. In this conditions, physicians are refrained from using corticosteroids and/or immunosuppressants agents because of the risk of favouring viral replication ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.009

    authors: Galeazzi M,Giannitti C,Manganelli S,Benucci M,Scarpato S,Bazzani C,Caporali R,Sebastiani GD

    更新日期:2008-12-01 00:00:00

  • Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).

    abstract::Autotaxin (ATX) is a 125-kD type II ectonucleotide pyrophosphatase/phosphodiesterase (ENPP2 or NPP2) originally discovered as an unknown "autocrine motility factor" in human melanoma cells. In addition to its pyrophosphatase/phosphodiesterase activities ATX has lysophospholipase D (lysoPLD) activity, catalyzing the co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.03.019

    authors: Sun Y,Zhang W,Evans JF,Floreani A,Zou Z,Nishio Y,Qi R,Leung PS,Bowlus CL,Gershwin ME

    更新日期:2016-08-01 00:00:00

  • CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.

    abstract::There is strong evidence that a quantitative and/or functional deficiency in CD4+CD25+ regulatory T cells (T(reg) cells) plays a key role in the pathogenesis of many human autoimmune diseases. Therefore, targeting regulatory T cells with novel forms of immunotherapy should provide a means for successfully battling aut...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2005.06.001

    authors: Beyersdorf N,Hanke T,Kerkau T,Hünig T

    更新日期:2006-01-01 00:00:00

  • Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature.

    abstract:OBJECTIVES:To assess the efficacy and safety of Rituximab (RTX) in adult primary central nervous system vasculitis (PCNSV). METHODS:We retrospectively assessed the effect of RTX in 6 patients with PCNSV. Five of the 6 were refractory to high dose glucocorticoids (GCs) and/or conventional immunosuppressants (IS). The s...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.12.002

    authors: Salvarani C,Brown RD Jr,Muratore F,Christianson TJH,Galli E,Pipitone N,Cassone G,Huston J III,Giannini C,Warrington K,Hunder GG

    更新日期:2019-04-01 00:00:00

  • Menopause in patients with autoimmune diseases.

    abstract::Menopause represents a time of significant clinical and hormonal change. Given the incompletely understood interrelationship between gonadal hormones and the immune system, it is possible that menopause may affect, or be affected by, the presence of autoimmune disease. Menopause has significant effects on a number of ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.006

    authors: Sammaritano LR

    更新日期:2012-05-01 00:00:00

  • Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

    abstract:BACKGROUND:According to criteria for the classification of Systemic Lupus Erythematosus (SLE), thrombocytopenia is one of the disease-defining hematologic disorders. Since the recognition of Antiphospholipid Syndrome (APS), thrombocytopenia was frequently reported but several studies yielded contradictory results on th...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2019.102395

    authors: Chock YP,Moulinet T,Dufrost V,Erkan D,Wahl D,Zuily S

    更新日期:2019-11-01 00:00:00

  • B cells and HCV: an infection model of autoimmunity.

    abstract::In addition to cause acute and chronic liver disease, hepatitis C virus (HCV) infection is frequently associated to autoimmune disorders, such as mixed cryoglobulinemia, primary glomerulonephritis, monoclonal gammopathy of undetermined significance and post-transplant proliferative disorders. Progression to malignant ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.03.008

    authors: Sansonno L,Tucci FA,Sansonno S,Lauletta G,Troiani L,Sansonno D

    更新日期:2009-12-01 00:00:00

  • Rho GTPase-mediated pathways in mature CD4+ T cells.

    abstract::Effective immune responses require the appropriate activation and differentiation of peripheral CD4(+) T cells. These processes need to be followed by the timely elimination of the responding T cells in order to restore T cell homeostasis. Defects in the appropriate regulation of T cell activation, expansion, and surv...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.044

    authors: Pernis AB

    更新日期:2009-01-01 00:00:00

  • Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.

    abstract::Antineutrophil cytoplasmic antibodies (ANCA) are the serological hallmark of some idiopathic systemic vasculitides, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and, to a lesser extent, Churg-Strauss syndrome (CCS), the so-called ANCA-associated vasculitides (AAV). ANCA were first det...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.08.008

    authors: Radice A,Bianchi L,Sinico RA

    更新日期:2013-02-01 00:00:00

  • Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature.

    abstract::Neonatal Lupus Syndrome (NLS) is a distinct clinical entity caused by transplacental passage of maternal anti-SSA/Ro antibodies (Ab). Mothers may have systemic lupus erythematosus, Sjögren syndrome, or other connective tissue disease, or may be completely healthy at the time of giving birth. NLS includes several clini...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.02.010

    authors: Zuppa AA,Riccardi R,Frezza S,Gallini F,Luciano RM,Alighieri G,Romagnoli C,De Carolis S

    更新日期:2017-04-01 00:00:00

  • Enteropathic spondyloarthritis: Results from a large nationwide database analysis.

    abstract:INTRODUCTION:Spondyloarthrits (SpA) share clinical, genetic and immunological features with Inflammatory Bowel Diseases (IBD), and enteropathic SpA (eSpA) represent the clinical evidence of the association between gut and joint diseases. This cross-sectional study aimed to report data of eSpA patients collected from th...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2019.102457

    authors: Picchianti-Diamanti A,Lorenzetti R,Chimenti MS,Luchetti MM,Conigliaro P,Canofari C,Benfaremo D,Bruzzese V,Laganà B,Perricone R,SIGR.

    更新日期:2020-02-01 00:00:00

  • Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis.

    abstract::Granulomatosis with polyangiitis (GPA) is an autoimmune systemic necrotizing small-vessel vasculitis associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA). Oto-neurological manifestations of ANCA-associated vasculitis according to PR3-ANCA positivity and MPO-ANCA positivity are usually reported...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.02.005

    authors: Iannella G,Greco A,Granata G,Manno A,Pasquariello B,Angeletti D,Didona D,Magliulo G

    更新日期:2016-07-01 00:00:00